X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

NICE Urged To Make The Kidney Cancer Treatment A Priority

Content Team by Content Team
7th February 2023
in News

NICE, the National Institute for Health and Care Excellence, has received a plea from the Kidney Cancer UK to bring about guidelines on the diagnosis and treatment of kidney cancer as a significant priority.

Although NHS England has commissioned NICE to go through the urgent work, the recent results of a survey conducted by Kidney Cancer UK suggest that the policies have to be framed sooner rather than later.

The survey brings to light the fact that nearly a third of patients have waited for their turn in excess of three months, right from first presenting to a doctor to being given a proper diagnosis. Moreover, as per the survey, 22% of the patients were initially misdiagnosed.

The charity also highlights the need to ensure that kidney cancer is identified early and how it could be rectified by seamless guidelines, both on referrals as well as diagnosis.

The survey puts forth the fact that over 40% of the kidney cancer patients are still in the queue with three to five weeks left until their scan results. The survey, surprisingly, also brings up the fact that 48% of kidney cancer in patients was discovered incidentally through a scan that was not predominantly done for that.

It is well to noted that patients were unhappy with the fact that when the diagnosis was made, the method used to share the result with them was uncalled for—it was often done over the phone.

The University of Cambridge’s Professor Grant Stewart stated in his analysis that the nature of the statistics in this survey has been deeply concerning because these diagnoses and services are occurring post-COVID-19. The fact that 40% of the patients are diagnosed at stage 3 or stage 4 downplays the NHS’s long-term plan of diagnosing three out of four cancers at stage 1 or stage 2 by 2028.

Associate Professor of Radiology from the University Hospital of Southampton, Dr. David Breen opines that one needs to get into less invasive and more effective treatments like Cryoablation when it comes to sub 4-5cms kidney tumours. This surely reflects the need of the patient and significantly spares the kidney function in the background. Although ablation might not be perfect for all kidney cancer patients, it must be discussed in the case of smaller kidney cancers.

Previous Post

ABPI In UK Sees Possibility of Revenue Clawback Rate Rise

Next Post

Twelve Digit National Drug Code Gets Proposed By The FDA

Related Posts

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Drugs Gain From Tardigrade Proteins, Says Research
Drug Development

Pharma Drugs Gain From Tardigrade Proteins, Says Research

22nd March 2023
Next Post
Usual Pharma Compliance Issues Noted In FDA Warning Letters

Twelve Digit National Drug Code Gets Proposed By The FDA

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In